(NASDAQ: OTLK)
Outlook Therapeutics share price is $1.5 & ₹130.45 as on 6 Mar 2025, 2.30 'hrs' IST
$1.5
▲
0.03
(2.04%)
Market is closed - opens 8 PM, 06 Mar 2025
View live Outlook Therapeutics share price in Dollar and Rupees. Guide to invest in Outlook Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Outlook Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
2.0%
Downside
Day's Volatility :5.47%
Upside
3.54%
42.0%
Downside
52 Weeks Volatility :93.23%
Upside
88.33%
in dollars & INR
It is very easy for Indian residents to invest directly in Outlook Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Outlook Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Outlook Therapeutics or OTLK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Outlook Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Outlook Therapeutics shares which would translate to 0.580 fractional shares of Outlook Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Outlook Therapeutics, in just a few clicks!
The Outlook Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Outlook Therapeutics investment value today
Current value as on today
₹23,481
Returns
Returns from Outlook Therapeutics Stock
Dollar Returns
₹4,963 (+4.96%)
BlackRock Inc
3.42%
Vanguard Group Inc
2.66%
Geode Capital Management, LLC
1.08%
UBS Group AG
0.90%
State Street Corp
0.78%
Rhumbline Advisers
0.59%
Buy
92%Buy
7%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Outlook Therapeutics(by analysts ranked 0 to 5 stars)
What analysts predicted
Upside of 566.67%
Target:
$10.00
Current:
$1.50
Sell
Neutral
Buy
Outlook Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Outlook Therapeutics share price today stands at $1.50, Open: $1.50 ; Previous Close: $1.47 ; High: $1.56 ; Low: $1.47 ; 52 Week High: $12.85 ; 52 Week Low: $0.87.
The stock opens at $1.50, after a previous close of $1.47. The stock reached a daily high of $1.56 and a low of $1.47, with a 52-week high of $12.85 and a 52-week low of $0.87.
Yes, Indians can invest in the Outlook Therapeutics (OTLK) from India.
With INDmoney, you can buy Outlook Therapeutics at 0 brokerage. The step-by-step process is as follows:
It is very easy to buy Outlook Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Yes, you can buy fractional shares of Outlook Therapeutics with INDmoney app.
To start investing in Outlook Therapeutics, You will need the following documents:
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
Today’s highest price of Outlook Therapeutics (OTLK) is $1.56.
Today’s lowest price of Outlook Therapeutics (OTLK) is $1.47.
52 Week High
$12.85
52 Week Low
$0.87
1 Month Returns
-20.54%
3 Months Returns
-81.2%
1 Year Returns
-81.85%
5 Years Returns
-89.67%
$12.02
-0.5%
$7.11
-0.14%
$5.88
+0.86%
$63.59
+1.05%
$2.38
+0.0%
$19.39
+1.47%
$3.87
+0.78%
$43.94
+0.71%